alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet

RxCUI: 1368034
RxNorm name: alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet
Display name: alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet
Full name: alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Alogliptin	ALOGLIPTIN	Padagis Israel Pharmaceuticals Ltd	b25f155a-1259-47c2-aa3b-7c1356e4c7f6	2025-04-11	Warnings, Adverse reactions	Exact identifier rxcui: 1368034
Nesina	ALOGLIPTIN	Takeda Pharmaceuticals America, Inc.	a3768c7e-aa4c-44d3-bc53-43bb7346c0b0	2025-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 1368034
Alogliptin	ALOGLIPTIN	Aphena Pharma Solutions - Tennessee, LLC	a05d6d17-79f9-4788-a4d5-467bca1a2d91	2022-10-18	Warnings, Adverse reactions	Exact identifier rxcui: 1368034

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
a3768c7e-aa4c-44d3-bc53-43bb7346c0b0	alogliptin 12.5 MG Oral Tablet [PSN] · alogliptin 12.5 MG Oral Tablet [SCD] · alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet [SY]	3	22	These highlights do not include all the information needed to use NESINA ® safely and effectively. See full prescribing information for NESINA. NESINA (alogliptin) tablets, for oral use Initial U.S. Approval: 2013	20250228
b25f155a-1259-47c2-aa3b-7c1356e4c7f6	alogliptin 12.5 MG Oral Tablet [PSN] · alogliptin 12.5 MG Oral Tablet [SCD] · alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet [SY]	3	12	These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013	20250411
a05d6d17-79f9-4788-a4d5-467bca1a2d91	alogliptin 12.5 MG Oral Tablet [PSN] · alogliptin 12.5 MG Oral Tablet [SCD] · alogliptin 12.5 MG (as alogliptin benzoate 17 MG) Oral Tablet [SY]	3	2	These highlights do not include all the information needed to use ALOGLIPTIN TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN TABLETS. Alogliptin Tablets, for oral use Initial U.S. Approval: 2013	20221018